AMGN Icon

$AMGN

$AMGN

Amgen

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The companys principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçets disease; Prolia to treat postmenopausal women with ...

Stocks

Total Asset Value

$19,537

▼20.45%from 30d ago

Holders

79

▲+16.18%from 30d ago

Monthly Transfer Volume

$2.30M

▲+839.17%from 30d ago

Amgen Metrics

Tokenized Public Stocks

10 Total